Impact of genomic aberrations on EFS. (A) Kaplan-Meier plot of the impact of del(13) on EFS for the 936 patients analyzed for this abnormality. (B) Impact of t(4;14), analyzed in 716 patients. (C) Value of del(17p) on EFS of 532 patients. The gray curve is for patients presenting the genomic abnormality, whereas the black curve represents the EFS of patients lacking the chromosomal aberration.